v3.24.1.1.u2
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows from Operating Activities    
Net loss $ (4,657,688) $ (12,895,136)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,806,375 1,425,904
Amortization of intangible asset   363,750
Noncash lease expense 94,767 108,660
Stock-based compensation 283,877 765,717
Change in fair value of contingent earn-out receivable, related party (1,000,000) (990,500)
Change in fair value of convertible promissory note, related party 96,000  
Unrealized gain on investments (3,022) (89,322)
Noncash interest expense 102  
Increase (decrease) in cash arising from changes in assets and liabilities, net of acquisitions:    
Accounts receivable (1,160,808) (16,938)
Other assets   (3,698,297)
Prepaid expenses and other current assets (351,249) 82,659
Inventory (536,862)  
Right-of-use assets   597,046
Deposits (26,622) 16,721
Accounts payable 683,929 (1,373,185)
Deferred revenue (1,798,182) 453,678
Accrued expenses and other liabilities 1,885,505 1,454,412
Net Cash Used In Operating Activities (4,683,878) (13,794,831)
Cash Flows from Investing Activities    
Purchase of short-term investments (681,876) (189,218)
Sale of short-term investments 2,762,215 15,300,444
Sale of intellectual property license 1,000,000  
Purchases of property and equipment (299,344) (1,624,931)
Net Cash Provided by Investing Activities 2,780,995 13,486,295
Cash Flows from Financing Activities    
Proceeds from issuance of convertible promissory note, related party 2,250,000  
Proceeds from sale of common stock 1,500,000  
Proceeds from sale of common stock via S-3 offering 8,403  
Proceeds from issuance of common stock under ESPP 12,904  
Stock issuance costs (265,350)  
Repayments of principal under finance lease (231,126) (298,523)
Net Cash Provided by (Used In) Financing Activities 3,274,831 (298,523)
Effect of exchange rate changes on cash and cash equivalents (2,029) (706)
Net Increase (Decrease) in Cash and Cash Equivalents 1,369,919 (607,765)
Cash and Cash Equivalents - Beginning of the Period 184,925 8,434,554
Cash and Cash Equivalents - End of the Period 1,554,844 7,826,789
Supplemental Disclosure for Cash Flow Information:    
Right-of-use assets surrendered upon financing lease modifications   $ (424,379)
Right-of-use assets surrendered upon operating lease modifications (105,237)  
Supplemental disclosure of non-cash investing and financing activities:    
Purchases of property and equipment included in accounts payable 202,988  
Reconciliation of cash and cash equivalents at March 31, 2024 and 2023    
Cash and cash equivalents of continuing operations $ 1,554,844  

Source

HTML PDF
ZIP